{"id":"https://openalex.org/W2359168355","doi":null,"title":"Effect of morphine dependence and abstinence on the expression of pro-dynorphin mRNA in Sprague-Dawley rats","display_name":"Effect of morphine dependence and abstinence on the expression of pro-dynorphin mRNA in Sprague-Dawley rats","alternate_titles":[],"publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2359168355","mag":"2359168355"},"language":"en","primary_location":{"id":"mag:2359168355","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=ZHMA200302010","pdf_url":null,"source":{"id":"https://openalex.org/S4306506130","display_name":"Chin J Psychiatry","issn_l":"1006-7884","issn":["1006-7884"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhonghua jingshenke zazhi","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2359168355"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061772200","display_name":"Xing-Wang Wan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Xing-Wang Wan","raw_affiliation_strings":["*, HUANG Mao, HE Ya-qin, et al"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"*, HUANG Mao, HE Ya-qin, et al","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5061772200"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/morphine-dependence","display_name":"morphine dependence","score":0.9900000095367432},{"id":"https://openalex.org/keywords/morphine-withdrawal","display_name":"morphine withdrawal","score":0.8259999752044678},{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.9039999842643738},{"id":"https://openalex.org/keywords/opioid-withdrawal","display_name":"opioid withdrawal","score":0.5180000066757202},{"id":"https://openalex.org/keywords/hypothalamus","display_name":"hypothalamus","score":0.8539999723434448},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.9750000238418579},{"id":"https://openalex.org/keywords/spinal-cord","display_name":"spinal cord","score":0.9739999771118164},{"id":"https://openalex.org/keywords/hippocampus","display_name":"hippocampus","score":0.9490000009536743},{"id":"https://openalex.org/keywords/pituitary-gland","display_name":"pituitary gland","score":0.9629999995231628},{"id":"https://openalex.org/keywords/chronic-morphine-treatment","display_name":"chronic morphine administration","score":0.7919999957084656}],"concepts":[{"id":"https://openalex.org/C151077648","wikidata":"https://www.wikidata.org/wiki/Q324076","display_name":"Dynorphin","level":5,"score":0.9546304941177368},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7199744582176208},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7127248644828796},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.6430315971374512},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.6404362320899963},{"id":"https://openalex.org/C2781181269","wikidata":"https://www.wikidata.org/wiki/Q5319233","display_name":"Dynorphin A","level":5,"score":0.5792604684829712},{"id":"https://openalex.org/C2777003273","wikidata":"https://www.wikidata.org/wiki/Q164386","display_name":"Hypothalamus","level":2,"score":0.5633003115653992},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.5229012370109558},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48758190870285034},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.4433092772960663},{"id":"https://openalex.org/C88016717","wikidata":"https://www.wikidata.org/wiki/Q417189","display_name":"Opioid peptide","level":4,"score":0.37222301959991455},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2809416651725769},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.22585386037826538},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10755378007888794}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2359168355","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=ZHMA200302010","pdf_url":null,"source":{"id":"https://openalex.org/S4306506130","display_name":"Chin J Psychiatry","issn_l":"1006-7884","issn":["1006-7884"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhonghua jingshenke zazhi","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2394191228","https://openalex.org/W2418197324","https://openalex.org/W2039133611","https://openalex.org/W2072757678","https://openalex.org/W2374594409","https://openalex.org/W2435293394","https://openalex.org/W2064981998","https://openalex.org/W2149738356","https://openalex.org/W2383482643","https://openalex.org/W2381011452"],"abstract_inverted_index":{"ObjectiveTo":[0],"investigate":[1],"the":[2,68,85,107,128,173],"expression":[3,48,69,86,108,129],"of":[4,22,25,44,49,71,88,104,110,125,131,164,168,175,180],"pro-dynorphin":[5,50,58,72,89,111,132],"mRNA":[6,51,133],"in":[7,73,82,90,112,134,147,152],"rats":[8,15,37],"following":[9],"morphine":[10,26,120,153,159,176],"dependence":[11,177],"and":[12,78,95,139,178],"abstinence.":[13],"MethodsThe":[14],"were":[16,40,143],"rendered":[17],"dependent":[18,154],"by":[19,61],"subcutaneous":[20],"injections":[21],"increasing":[23],"doses":[24],"from":[27,115],"10":[28],"to":[29,117,158,161,172],"40":[30],"mg/kg":[31],"for":[32],"6":[33],"consecutive":[34],"days.":[35],"The":[36,47],"as":[38],"controls":[39],"administered":[41],"similar":[42],"volume":[43],"normal":[45],"saline.":[46],"was":[52],"assayed":[53],"using":[54],"radioactive":[55],"32":[56],"P-labelled":[57],"cDNA":[59],"probe":[60],"Northern":[62],"blot":[63],"hybridization.":[64],"Results":[65],"Comparing":[66],"with":[67],"level":[70],"hypothalamus":[74,91,135],"(34.36\u00b11.46),":[75],"striatum":[76,93,137],"(31.24\u00b12.83)":[77],"spinal":[79,96,140],"cord":[80,97,141],"(27.60\u00b12.89)":[81],"control":[83],"rats,":[84,169],"levels":[87,109,130],"(23.88\u00b11.62),":[92],"(19.87\u00b12.03)":[94],"(13.36\u00b11.46)":[98],"decreased":[99],"significantly":[100],"after":[101,119],"chronic":[102],"administration":[103],"morphine.":[105],"However,":[106],"hippocampus":[113],"increased":[114],"(25.87\u00b11.74)":[116],"(29.67\u00b13.23)":[118],"treatment.":[121],"After":[122],"60":[123],"minutes":[124],"naloxone":[126],"administration,":[127],"(10.22\u00b11.22),":[136],"(5.90\u00b10.84)":[138],"(2.99\u00b10.48)":[142],"lower,":[144],"while":[145],"higher":[146],"pituitary":[148],"(26.72\u00b11.79)":[149],"than":[150],"that":[151],"rats.":[155],"ConclusionChronic":[156],"exposure":[157],"appears":[160],"induce":[162],"modification":[163],"endogeneous":[165],"dynorphin":[166],"system":[167],"which":[170],"contributes":[171],"development":[174],"precipitation":[179],"abstinence":[181],"syndrome.":[182]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2359168355","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
